|
FAM76A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02450270489385E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.29709584687043E-11 |
| Normal-vs-Stage2 |
7.9258999996501E-07 |
| Normal-vs-Stage3 |
2.31459296173853E-12 |
| Normal-vs-Stage4 |
5.91210413958265E-11 |
| Stage1-vs-Stage2 |
1.697170E-01 |
| Stage1-vs-Stage3 |
8.275900E-02 |
| Stage1-vs-Stage4 |
2.749600E-01 |
| Stage2-vs-Stage3 |
2.283700E-02 |
| Stage2-vs-Stage4 |
7.724100E-02 |
| Stage3-vs-Stage4 |
8.429800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.4602099791291E-12 |
| Normal-vs-AfricanAmerican |
7.633000E-04 |
| Normal-vs-Asian |
2.30682140056615E-12 |
| Caucasian-vs-AfricanAmerican |
3.048200E-02 |
| Caucasian-vs-Asian |
3.613200E-01 |
| AfricanAmerican-vs-Asian |
3.211500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.89972515285808E-13 |
| Normal-vs-Female |
5.82422998718357E-12 |
| Male-vs-Female |
5.097400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.58230112240676E-11 |
| Normal-vs-Age(41-60Yrs) |
5.24325027839723E-12 |
| Normal-vs-Age(61-80Yrs) |
1.18079990230058E-10 |
| Normal-vs-Age(81-100Yrs) |
3.241200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.991200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.271200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.674800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.024400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.220400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.446600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.79600999999918E-05 |
| Classical-VS-Follicular |
1.072260E-02 |
| Classical-VS-Other |
8.114400E-01 |
| Classical-VS-Normal |
3.83839626749705E-11 |
| Tall-VS-Follicular |
3.87759999664894E-08 |
| Tall-VS-Other |
6.712200E-02 |
| Tall-VS-Normal |
9.99200722162641E-16 |
| Follicular-VS-Other |
2.957800E-01 |
| Follicular-VS-Normal |
1.86359999987395E-07 |
| Other-VS-Normal |
1.983540E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.10702591327572E-15 |
| Normal-vs-N1 |
1.08919984143085E-10 |
| N0-vs-N1 |
2.527200E-01 |
|
|
